NEW YORK (Reuters) - Tesla (NASDAQ: TSLA) CEO Elon Musk spoke at a JPMorgan Chase (NYSE: JPM) conference on Thursday which ...

Why the national AI strategy can’t waitBy Nazareen Ebrahim, AI Ethics and Communications SpecialistIssued by Naz Consulting InternationalJohannesburg, 07 Feb 2025Visit our press officeAs South Africa ...

South African President Cyril Ramaphosa said on Thursday that his country "will not be bullied," days after U.S. President ...

Pfizer CEO Albert Bourla told investors he dined with RFK Jr, a vaccine skeptic and nominee to head HHS. They discussed ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 78 tables and 119 figures, this 215-page report ?Global Biopharmaceuticals Market 2023-2033 by Product Type, Testing ...

Drugmaker Pfizer posted a better than expected fourth quarter profit on Thursday, helped by cost cuts and a ...

Pfizer Inc. (NYSE: PFE) today announced positive topline results from the progression-free survival (PFS) analysis of the Phase 3 BREAKWATER study of ...

Drug major Pfizer Inc. (PFE) announced Monday positive topline results from the progression-free survival or PFS analysis of the ...

Pfizer Inc. today announced positive topline results from the progression-free survival (PFS) analysis of the Phase 3 BREAKWATER study of BRAFTOVI® (encorafenib) in combination with cetuximab ...

South America, Asia Pacific, Middle East and Africa) - Industry Growth Forecast to 2032 Organ Transplantation Immunosuppressive Drug Market Overview Growing transplant procedures and improved organ ...

Increasing adoption of digital health tools in diagnostics and therapy. Digital Medicine Market growth was valued at 6.35 Billion USD in 2023. Digital Medicine Market Industry is expected to grow from ...

Pfizer’s BREAKWATER trial of Braftovi combo regimen demonstrates improved response in patients with BRAF V600E-mutant metastatic colorectal cancer: New York Tuesday, January 28, ...